Summit Securities Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,400
Closed -$489K 1053
2024
Q4
$489K Hold
3,400
0.1% 138
2024
Q3
$506K Buy
+3,400
New +$488K 0.13% 98

Other funds holding RGEN

Summit Securities Group's RGEN Position: Q2 2025 in Review

Summit Securities Group sold out of Repligen (RGEN) in Q2 2025, closing a stake of 1,298 shares — an estimated $165K sold.

Summit Securities Group first reported a position in RGEN in Q1 2025 and held it in 1 quarter. The position peaked at $165K in Q1 2025. 443 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Summit Securities Group reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Summit Securities Group sold 1,298 Repligen shares in Q2 2025, an estimated $165K.
  • Summit Securities Group first reported a position in Repligen in Q1 2025 and held it in 1 quarter.
  • Summit Securities Group's Repligen position peaked at $165K in Q1 2025.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Summit Securities Group's 13F filing for Q2 2025, filed 12 Aug 2025.